Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 20 studies | 22% ± 4% | |
oligodendrocyte | 12 studies | 38% ± 18% | |
CD16-positive, CD56-dim natural killer cell, human | 12 studies | 25% ± 7% | |
oligodendrocyte precursor cell | 9 studies | 35% ± 19% | |
CD16-negative, CD56-bright natural killer cell, human | 8 studies | 22% ± 3% | |
endothelial cell | 8 studies | 26% ± 8% | |
mature NK T cell | 6 studies | 19% ± 4% | |
gamma-delta T cell | 6 studies | 18% ± 2% | |
ionocyte | 5 studies | 30% ± 7% | |
CD8-positive, alpha-beta T cell | 5 studies | 21% ± 5% | |
effector memory CD8-positive, alpha-beta T cell | 5 studies | 18% ± 4% | |
epithelial cell | 5 studies | 30% ± 11% | |
plasmacytoid dendritic cell | 5 studies | 21% ± 5% | |
classical monocyte | 4 studies | 22% ± 6% | |
neuron | 4 studies | 32% ± 18% | |
endothelial cell of lymphatic vessel | 4 studies | 20% ± 6% | |
astrocyte | 4 studies | 31% ± 7% | |
macrophage | 4 studies | 23% ± 3% | |
conventional dendritic cell | 3 studies | 28% ± 9% | |
non-classical monocyte | 3 studies | 31% ± 5% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 20% ± 6% | |
basal cell | 3 studies | 22% ± 5% | |
glutamatergic neuron | 3 studies | 36% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 10999.41 | 2642 / 2642 | 100% | 161.14 | 705 / 705 |
ovary | 100% | 4894.37 | 180 / 180 | 100% | 31.28 | 430 / 430 |
thymus | 100% | 4060.86 | 653 / 653 | 100% | 37.35 | 605 / 605 |
uterus | 100% | 4334.02 | 170 / 170 | 100% | 37.88 | 459 / 459 |
skin | 100% | 4174.55 | 1808 / 1809 | 100% | 44.13 | 472 / 472 |
kidney | 100% | 3257.15 | 89 / 89 | 100% | 31.40 | 899 / 901 |
prostate | 100% | 3688.74 | 245 / 245 | 100% | 34.01 | 500 / 502 |
esophagus | 100% | 4192.33 | 1445 / 1445 | 99% | 25.28 | 182 / 183 |
liver | 100% | 2787.10 | 225 / 226 | 100% | 24.15 | 405 / 406 |
stomach | 100% | 3263.89 | 359 / 359 | 99% | 24.42 | 284 / 286 |
breast | 100% | 4165.33 | 459 / 459 | 99% | 30.25 | 1110 / 1118 |
intestine | 100% | 4006.69 | 965 / 966 | 99% | 23.05 | 523 / 527 |
lung | 100% | 4004.68 | 576 / 578 | 99% | 29.39 | 1149 / 1155 |
adrenal gland | 100% | 4284.57 | 258 / 258 | 99% | 32.90 | 228 / 230 |
bladder | 100% | 4064.62 | 21 / 21 | 99% | 30.27 | 499 / 504 |
pancreas | 96% | 1859.95 | 316 / 328 | 99% | 28.95 | 177 / 178 |
adipose | 100% | 4242.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 37.69 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.20 | 29 / 29 |
muscle | 100% | 14650.84 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4184.72 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.13 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.56 | 1 / 1 |
blood vessel | 99% | 3188.56 | 1328 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3457.69 | 912 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 4106.38 | 843 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000183 | Biological process | rDNA heterochromatin formation |
GO_0045723 | Biological process | positive regulation of fatty acid biosynthetic process |
GO_0071872 | Biological process | cellular response to epinephrine stimulus |
GO_0051301 | Biological process | cell division |
GO_0042325 | Biological process | regulation of phosphorylation |
GO_0070446 | Biological process | negative regulation of oligodendrocyte progenitor proliferation |
GO_0051775 | Biological process | response to redox state |
GO_0007084 | Biological process | mitotic nuclear membrane reassembly |
GO_0006914 | Biological process | autophagy |
GO_1900119 | Biological process | positive regulation of execution phase of apoptosis |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0042177 | Biological process | negative regulation of protein catabolic process |
GO_0031641 | Biological process | regulation of myelination |
GO_0051781 | Biological process | positive regulation of cell division |
GO_0044546 | Biological process | NLRP3 inflammasome complex assembly |
GO_0045087 | Biological process | innate immune response |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0043687 | Biological process | post-translational protein modification |
GO_0031507 | Biological process | heterochromatin formation |
GO_0010801 | Biological process | negative regulation of peptidyl-threonine phosphorylation |
GO_0045843 | Biological process | negative regulation of striated muscle tissue development |
GO_0040029 | Biological process | epigenetic regulation of gene expression |
GO_1900226 | Biological process | negative regulation of NLRP3 inflammasome complex assembly |
GO_0090042 | Biological process | tubulin deacetylation |
GO_0006476 | Biological process | protein deacetylation |
GO_0007096 | Biological process | regulation of exit from mitosis |
GO_0031509 | Biological process | subtelomeric heterochromatin formation |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0034983 | Biological process | peptidyl-lysine deacetylation |
GO_0043388 | Biological process | positive regulation of DNA binding |
GO_0061433 | Biological process | cellular response to caloric restriction |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0044242 | Biological process | cellular lipid catabolic process |
GO_1900195 | Biological process | positive regulation of oocyte maturation |
GO_2000378 | Biological process | negative regulation of reactive oxygen species metabolic process |
GO_0051987 | Biological process | positive regulation of attachment of spindle microtubules to kinetochore |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0022011 | Biological process | myelination in peripheral nervous system |
GO_0051321 | Biological process | meiotic cell cycle |
GO_0045836 | Biological process | positive regulation of meiotic nuclear division |
GO_0021762 | Biological process | substantia nigra development |
GO_1902725 | Biological process | negative regulation of satellite cell differentiation |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0044224 | Cellular component | juxtaparanode region of axon |
GO_0072687 | Cellular component | meiotic spindle |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0005730 | Cellular component | nucleolus |
GO_0043219 | Cellular component | lateral loop |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005814 | Cellular component | centriole |
GO_0030496 | Cellular component | midbody |
GO_0005886 | Cellular component | plasma membrane |
GO_0005874 | Cellular component | microtubule |
GO_0005739 | Cellular component | mitochondrion |
GO_0000792 | Cellular component | heterochromatin |
GO_0043204 | Cellular component | perikaryon |
GO_0005813 | Cellular component | centrosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0097386 | Cellular component | glial cell projection |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0043209 | Cellular component | myelin sheath |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005677 | Cellular component | chromatin silencing complex |
GO_0043220 | Cellular component | Schmidt-Lanterman incisure |
GO_0005829 | Cellular component | cytosol |
GO_0033010 | Cellular component | paranodal junction |
GO_0030426 | Cellular component | growth cone |
GO_0033270 | Cellular component | paranode region of axon |
GO_0005819 | Cellular component | spindle |
GO_0008134 | Molecular function | transcription factor binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0046970 | Molecular function | NAD-dependent histone H4K16 deacetylase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_1990404 | Molecular function | NAD+-protein ADP-ribosyltransferase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0035035 | Molecular function | histone acetyltransferase binding |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0042826 | Molecular function | histone deacetylase binding |
GO_0003950 | Molecular function | NAD+ ADP-ribosyltransferase activity |
GO_0004407 | Molecular function | histone deacetylase activity |
GO_0042903 | Molecular function | tubulin deacetylase activity |
GO_0017136 | Molecular function | NAD-dependent histone deacetylase activity |
GO_0070403 | Molecular function | NAD+ binding |
GO_0034979 | Molecular function | NAD-dependent protein lysine deacetylase activity |
GO_0140773 | Molecular function | NAD-dependent protein demyristoylase activity |
GO_0005515 | Molecular function | protein binding |
GO_0033558 | Molecular function | protein lysine deacetylase activity |
GO_0140774 | Molecular function | NAD-dependent protein depalmitoylase activity |
Gene name | SIRT2 |
Protein name | Sirtuin 2 NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) NAD-dependent protein deacetylase sirtuin-2 (NAD-dependent protein defatty-acylase sirtuin-2) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) |
Synonyms | SIR2L SIR2L2 |
Description | FUNCTION: NAD-dependent protein deacetylase, which deacetylates internal lysines on histone and alpha-tubulin as well as many other proteins such as key transcription factors . Participates in the modulation of multiple and diverse biological processes such as cell cycle control, genomic integrity, microtubule dynamics, cell differentiation, metabolic networks, and autophagy . Plays a major role in the control of cell cycle progression and genomic stability . Functions in the antephase checkpoint preventing precocious mitotic entry in response to microtubule stress agents, and hence allowing proper inheritance of chromosomes . Positively regulates the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase complex activity by deacetylating CDC20 and FZR1, then allowing progression through mitosis . Associates both with chromatin at transcriptional start sites (TSSs) and enhancers of active genes . Plays a role in cell cycle and chromatin compaction through epigenetic modulation of the regulation of histone H4 'Lys-20' methylation (H4K20me1) during early mitosis . Specifically deacetylates histone H4 at 'Lys-16' (H4K16ac) between the G2/M transition and metaphase enabling H4K20me1 deposition by KMT5A leading to ulterior levels of H4K20me2 and H4K20me3 deposition throughout cell cycle, and mitotic S-phase progression . Deacetylates KMT5A modulating KMT5A chromatin localization during the mitotic stress response . Deacetylates also histone H3 at 'Lys-57' (H3K56ac) during the mitotic G2/M transition . Upon bacterium Listeria monocytogenes infection, deacetylates 'Lys-18' of histone H3 in a receptor tyrosine kinase MET- and PI3K/Akt-dependent manner, thereby inhibiting transcriptional activity and promoting late stages of listeria infection . During oocyte meiosis progression, may deacetylate histone H4 at 'Lys-16' (H4K16ac) and alpha-tubulin, regulating spindle assembly and chromosome alignment by influencing microtubule dynamics and kinetochore function . Deacetylates histone H4 at 'Lys-16' (H4K16ac) at the VEGFA promoter and thereby contributes to regulate expression of VEGFA, a key regulator of angiogenesis . Deacetylates alpha-tubulin at 'Lys-40' and hence controls neuronal motility, oligodendroglial cell arbor projection processes and proliferation of non-neuronal cells . Phosphorylation at Ser-368 by a G1/S-specific cyclin E-CDK2 complex inactivates SIRT2-mediated alpha-tubulin deacetylation, negatively regulating cell adhesion, cell migration and neurite outgrowth during neuronal differentiation . Deacetylates PARD3 and participates in the regulation of Schwann cell peripheral myelination formation during early postnatal development and during postinjury remyelination . Involved in several cellular metabolic pathways . Plays a role in the regulation of blood glucose homeostasis by deacetylating and stabilizing phosphoenolpyruvate carboxykinase PCK1 activity in response to low nutrient availability . Acts as a key regulator in the pentose phosphate pathway (PPP) by deacetylating and activating the glucose-6-phosphate G6PD enzyme, and therefore, stimulates the production of cytosolic NADPH to counteract oxidative damage . Maintains energy homeostasis in response to nutrient deprivation as well as energy expenditure by inhibiting adipogenesis and promoting lipolysis . Attenuates adipocyte differentiation by deacetylating and promoting FOXO1 interaction to PPARG and subsequent repression of PPARG-dependent transcriptional activity . Plays a role in the regulation of lysosome-mediated degradation of protein aggregates by autophagy in neuronal cells . Deacetylates FOXO1 in response to oxidative stress or serum deprivation, thereby negatively regulating FOXO1-mediated autophagy . Deacetylates a broad range of transcription factors and co-regulators regulating target gene expression. Deacetylates transcriptional factor FOXO3 stimulating the ubiquitin ligase SCF(SKP2)-mediated FOXO3 ubiquitination and degradation (By similarity). Deacetylates HIF1A and therefore promotes HIF1A degradation and inhibition of HIF1A transcriptional activity in tumor cells in response to hypoxia . Deacetylates RELA in the cytoplasm inhibiting NF-kappaB-dependent transcription activation upon TNF-alpha stimulation . Inhibits transcriptional activation by deacetylating p53/TP53 and EP300 . Deacetylates also EIF5A . Functions as a negative regulator on oxidative stress-tolerance in response to anoxia-reoxygenation conditions . Plays a role as tumor suppressor . In addition to protein deacetylase activity, also has activity toward long-chain fatty acyl groups and mediates protein-lysine demyristoylation and depalmitoylation of target proteins, such as ARF6 and KRAS, thereby regulating their association with membranes . .; FUNCTION: [Isoform 1]: Deacetylates EP300, alpha-tubulin and histone H3 and H4. .; FUNCTION: [Isoform 2]: Deacetylates EP300, alpha-tubulin and histone H3 and H4. .; FUNCTION: [Isoform 5]: Lacks deacetylation activity, at least toward known SIRT2 targets. . |
Accessions | ENST00000443898.5 ENST00000423526.5 ENST00000420440.5 E7EWX6 F8WBT6 C9JZQ0 ENST00000381766.8 ENST00000451193.5 Q8IXJ6 F8WDM4 C9J3U7 ENST00000392081.6 [Q8IXJ6-2] B5MCS1 ENST00000249396.12 [Q8IXJ6-1] F8WCF4 ENST00000414941.5 F8WF57 ENST00000358931.9 ENST00000407552.5 C9JR33 A0A0A0MRF5 ENST00000634533.2 [Q8IXJ6-1] ENST00000447739.1 ENST00000437828.5 ENST00000635478.1 [Q8IXJ6-2] |